Grassi Investment Management Fate Therapeutics Inc Transaction History
Grassi Investment Management
- $1.13 Billion
- Q2 2024
A detailed history of Grassi Investment Management transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Grassi Investment Management holds 18,000 shares of FATE stock, worth $72,359. This represents 0.01% of its overall portfolio holdings.
Number of Shares
18,000
Previous 18,000
-0.0%
Holding current value
$72,359
Previous $132,000
55.3%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding FATE
# of Institutions
190Shares Held
123MCall Options Held
15KPut Options Held
14K-
Redmile Group, LLC San Francisco, CA13.2MShares$52.9 Million2.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$42.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$40.7 Million0.0% of portfolio
-
Boxer Capital, LLC San Diego, CA8.22MShares$33 Million1.5% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.57MShares$22.4 Million0.6% of portfolio
About FATE THERAPEUTICS INC
- Ticker FATE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,000,304
- Market Cap $390M
- Description
- Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...